N(6)-(4-hydroxyisopentenyl)-2-methylthioadenosine: RN given refers to cpd without isomeric designation 8/2/83 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6440977 |
| MeSH ID | M0110490 |
| Synonym |
|---|
| 2-methylthioribosylzeatin |
| 2-methylthio-cis-ribozeatin |
| (2r,3s,4r,5r)-2-(hydroxymethyl)-5-[6-[[(e)-4-hydroxy-3-methylbut-2-enyl]amino]-2-methylsulfanylpurin-9-yl]oxolane-3,4-diol |
| 26190-61-4 |
| 2-methylthiozeatin riboside |
| adenosine, n-(4-hydroxy-3-methyl-2-butenyl)-2-(methylthio)- |
| 2-methylthio-n(6)-(4-hydroxyisopentenyl)adenosine |
| n(6)-(4-hydroxyisopentenyl)-2-methylthioadenosine |
| DTXSID501017778 |
| (2r,3r,4s,5r)-2-(6-(((e)-4-hydroxy-3-methylbut-2-en-1-yl)amino)-2-(methylthio)-9h-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.02) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||